This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

The University of California Berkeley and UC San Francisco announced this week the launch of the Laboratory for Genomics Research, in which scientists from both institutions will use CRISPR gene ...

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Ulrike Künzel, Associate Director in the Functional Genomics department at AstraZeneca, about the application of arrayed ...

Dublin, Ireland, and Cheshire, UK, 04 September 2024: ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and Medicines Discovery Catapult (‘MDC’), an independent, not-for-profit drug ...

New partnership network combines the power of automated CRISPR cell line engineering with phenotypic, functional and multi-omic assays to optimize research workflows. Synthego launches CRISPR ...

Third Rock Ventures has launched a new cancer drug discovery and development company, Tango Therapeutics, with a $55 million Series A investment. The new firm, based in Cambridge, MA, is exploiting a ...

CRISPR gene editing has revolutionized the field of molecular biology, offering precise, efficient, and versatile tools for genome modification. The technology has rapidly evolved beyond the original ...

Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to ...

DUBLIN--(BUSINESS WIRE)--ERS Genomics Limited (‘ERS’) is pleased to announce ATLATL Innovation Centre (‘ATLATL’) as its non-exclusive agent for licensing ERS’ intellectual property for commercial ...